person

Per D.

Country
Sweden
Department
Medicincentrum

Research Overview

Data & Insights

medical_services
Primary Speciality
Main therapeutic area

handshake
Return Partnerships
Recurring site collaborations
0
Sites with multiple studies

Has run more than one trial at 0 of 6 partner sites.

Specializations

Transthyretin Amyloidosis

Investigates hereditary transthyretin amyloidosis presenting as polyneuropathy and cardiomyopathy, aiming to improve disease‑specific outcomes.

  • ATTRv‑PN management
  • ATTR‑CM therapeutic strategies
  • Biomarker development for amyloid burden
  • Patient‐reported outcome measures

Emphasis on early diagnosis and disease‑modifying interventions.

Hematologic Malignancies

Focuses on aggressive blood cancers such as acute lymphoblastic leukaemia, acute myeloid leukaemia, and various lymphomas.

  • Targeted therapies for pediatric AML
  • Combination regimens in relapsed/refractory lymphoma
  • Immunotherapy integration in ALL
  • Maintenance strategies post‑stem cell transplantation

Dedicated to enhancing survival while reducing treatment toxicity.

Cardiovascular & Thrombotic Disorders

Addresses conditions like atrial fibrillation, coronary artery disease, and heart failure subtypes.

  • Anticoagulation in CKD‑stage 5 patients
  • Early rhythm control with catheter ablation
  • Novel agents for heart failure with reduced ejection fraction
  • Platelet inhibition after coronary artery bypass grafting

Targets reduction of cardiovascular events and optimization of cardiac function.

Neurological & Neurodegenerative Diseases

Encompasses disorders such as amyotrophic lateral sclerosis, mild cognitive impairment, and rare brain tumors.

  • Neuroprotective agents for ALS
  • Cognitive preservation in early Alzheimer‑type dementia
  • Targeted therapies for atypical teratoid/rhabdoid tumors
  • Management of hydrocephalus in premature infants

Prioritizes disease progression delay and quality of life improvement.

Respiratory & Pulmonary Conditions

Investigates chronic and acute lung diseases including chronic obstructive pulmonary disease and severe viral infections.

  • Beta‑blocker impact on COPD exacerbations
  • SGLT2 inhibitor role in postoperative atrial fibrillation
  • Antiviral strategies for high‑risk COVID‑19 outpatients
  • Management of severe viral lung infections

Focuses on reducing morbidity and enhancing respiratory function.

Related Investigators

Researchers in similar fields or departments

Want to know more about this investigator?

We can share extended profile information and contact details.

Is something out of date?

Tell us what needs correcting and we'll update this profile.